Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Holaira closes $42mm Series D

Executive Summary

Holaira Inc. (medical devices for obstructive lung diseases) closed a $42mm Series D financing led by Vertex Venture Holdings, which adds a board member and was joined by Windham Venture Partners, two strategic investors, and returning shareholders Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures. Funds will support the firm’s first randomized clinical trial with a sham control for targeted lung denervation therapy.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies